Outcomes Following Port-a-catheter Placement in the Medicare Population

Overview

Journal Surg Open Sci

Specialty General Surgery

Date 2021 May 3

PMID 33937739

Authors

Syed I Khalid

Samantha Maasarani

Rachyl M Shanker

Aaron Lee Wiegmann

Rita Wu

Nicholas J Skertich

Samantha L Terranella

Laura DeCesare

Edie Y Chan

Affiliations

Soon will be listed here.

Abstract

Background: We aimed to evaluate the long-term complication profile associated with port-a-catheter placement.

Methods: Patients undergoing port-a-catheter placement from 2007 to 2012 with 5-year follow up were identified. Descriptive statistics, tests, and multivariate regression models were analyzed.

Results: Any complication occurring within 5 years postoperatively was common (59.04%, n = 53,353). Arrhythmogenic (32.66%, n = 30,625) and thrombovascular (36.80%, n = 34,499) complications were more common than infection (17.86%, n = 16,745) and mechanical (10.31%, n = 9,670) complications. Multivariate analysis demonstrated that history of atrial fibrillation is a risk factor for developing any complication (odds ratio 7.99, 95% confidence interval 7.29-8.77).

Conclusion: Patients with history of atrial fibrillation have increased odds of developing infectious, thrombovascular, mechanical, and arrhythmogenic complications with port-a-catheter placement. This study is the first to show that postprocedure arrhythmias occur at significant rates within the 5-year follow-up period. We caution that development of new arrhythmia should be monitored throughout a prolonged follow-up period. We hope our analysis encourages multidisciplinary coordination of patients with ports so that implants are promptly removed when they are no longer needed to avoid these complications.

References

Lefrant J, MULLER L, de la Coussaye J, Prudhomme M, Ripart J, Gouzes C . Risk factors of failure and immediate complication of subclavian vein catheterization in critically ill patients. Intensive Care Med. 2002; 28(8):1036-41. DOI: 10.1007/s00134-002-1364-9. View

Madabhavi I, Patel A, Sarkar M, Anand A, Panchal H, Parikh S . A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience. Clin Med Insights Oncol. 2017; 11:1179554917691031. PMC: 5395272. DOI: 10.1177/1179554917691031. View

Dysarz 3rd F, Fiorillo M, Davidson P . Complications of subcutaneous injection ports. Mt Sinai J Med. 1998; 65(4):289-91. View

Schwarz R, Groeger J, Coit D . Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer. 1997; 79(8):1635-40. View

Yildizeli B, Lacin T, Batirel H, Yuksel M . Complications and management of long-term central venous access catheters and ports. J Vasc Access. 2006; 5(4):174-8. DOI: 10.1177/112972980400500407. View

Marcy P, Magne N, Castadot P, Bailet C, Macchiavello J, Namer M . Radiological and surgical placement of port devices: a 4-year institutional analysis of procedure performance, quality of life and cost in breast cancer patients. Breast Cancer Res Treat. 2005; 92(1):61-7. DOI: 10.1007/s10549-005-1711-y. View

Liu J, Tseng H, Chen C, Chern M, Chang C . Percutaneous retrieval of 20 centrally dislodged Port-A catheter fragments. Clin Imaging. 2004; 28(3):223-9. DOI: 10.1016/S0899-7071(03)00119-0. View

Vescia S, Baumgartner A, Jacobs V, Kiechle-Bahat M, Rody A, Loibl S . Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2007; 19(1):9-15. DOI: 10.1093/annonc/mdm272. View

Denny M, Frank L . Ventricular tachycardia secondary to Port-a-Cath fracture and embolization. J Emerg Med. 2003; 24(1):29-34. DOI: 10.1016/s0736-4679(02)00664-9. View

10.

Lambert M, Chadwick G, McMahon A, Scarffe J . Experience with the Portacath. Hematol Oncol. 1988; 6(1):57-63. DOI: 10.1002/hon.2900060109. View

11.

Ballarini C, Intra M, Ceretti A, Cordovana A, Pagani M, Farina G . Complications of subcutaneous infusion port in the general oncology population. Oncology. 1999; 56(2):97-102. DOI: 10.1159/000011947. View

12.

Minichsdorfer C, Fureder T, Mahr B, Berghoff A, Heynar H, Dressler A . A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports. Clin J Oncol Nurs. 2016; 20(2):175-80. DOI: 10.1188/16.CJON.175-180. View

13.

Cil B, Canyigit M, Peynircioglu B, Hazirolan T, Carkaci S, Cekirge S . Subcutaneous venous port implantation in adult patients: a single center experience. Diagn Interv Radiol. 2006; 12(2):93-8. View

14.

Hsieh C, Weng H, Huang W, Wang W, Kao C, Lu M . Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol. 2009; 15(37):4709-14. PMC: 2754519. DOI: 10.3748/wjg.15.4709. View

15.

Okada S, Shiraishi A, Yamashiro Y, Inoue T, Tsuge D, Aida M . A retrospective statistical analysis of the late complications associated with central venous port placements. Jpn J Radiol. 2014; 33(1):21-5. DOI: 10.1007/s11604-014-0375-0. View

16.

Shim J, Seo T, Song M, Cha I, Kim J, Choi C . Incidence and risk factors of infectious complications related to implantable venous-access ports. Korean J Radiol. 2014; 15(4):494-500. PMC: 4105813. DOI: 10.3348/kjr.2014.15.4.494. View

17.

Teichgraber U, Kausche S, Nagel S, Gebauer B . Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems. Eur Radiol. 2011; 21(6):1224-32. DOI: 10.1007/s00330-010-2045-7. View

18.

Monreal M, Davant E . Thrombotic complications of central venous catheters in cancer patients. Acta Haematol. 2001; 106(1-2):69-72. DOI: 10.1159/000046591. View

19.

Nakamura T, Sasaki J, Asari Y, Sato T, Torii S, Watanabe M . Complications after implantation of subcutaneous central venous ports (PowerPort). Ann Med Surg (Lond). 2017; 17:1-6. PMC: 5358939. DOI: 10.1016/j.amsu.2017.03.014. View

20.

Lemmers N, Gels M, Sleijfer D, Plukker J, van der Graaf W, de Langen Z . Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol. 1996; 14(11):2916-22. DOI: 10.1200/JCO.1996.14.11.2916. View